Announcements

  • FDA approves first oral liquid treatment for C. difficile-associated diarrhea

    7 years ago
    CutisPharma announced that the FDA has approved Firvanq, an oral liquid for the treatment of Clostridium difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus, according to a press release.